Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.89B |
| 2 |
Apple
AAPL
|
+$1.71B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.18B |
| 4 |
Pfizer
PFE
|
+$1.15B |
| 5 |
Duke Energy
DUK
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$1.54B |
| 2 |
Medtronic
MDT
|
+$1.44B |
| 3 |
Eli Lilly
LLY
|
+$1.39B |
| 4 |
NextEra Energy
NEE
|
+$1.1B |
| 5 |
JPMorgan Chase
JPM
|
+$1.02B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.56% |
| 2 | Technology | 19.3% |
| 3 | Financials | 12.11% |
| 4 | Industrials | 10.24% |
| 5 | Consumer Discretionary | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Akebia Therapeutics
AKBA
$354M
| $98.8M | 0.02% |
7,274,723
+5,549,182
| +322% | +$57.4M |
|
|
FMTX
527
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $98.4M | 0.02% |
+2,175,113
| New | +$94.3M |
|
528
Delek US
DK
$4.06B
| $98.4M | 0.02% |
5,653,620
+108,520
| +2% | +$2.07M |
|
|
JBGS
529
JBG SMITH
JBGS
$698M
| $98.2M | 0.02% |
3,319,924
+407,050
| +14% | +$12.6M |
|
530
BCE
BCE
$20.5B
| $98.1M | 0.02% |
2,360,244
-2,400,465
| -50% | -$98.8M |
|
531
Rexford Industrial Realty
REXR
$8.25B
| $97.9M | 0.02% |
2,362,011
+18,033
| +0.8% | +$724K |
|
532
OneMain Financial
OMF
$7.53B
| $97.4M | 0.02% |
3,970,089
-252,504
| -6% | -$5.75M |
|
|
AVNS
533
DELISTED
Avanos Medical
AVNS
| $96.8M | 0.02% |
3,292,757
+1,042,636
| +46% | +$30.2M |
|
534
International Paper
IP
$22.4B
| $96.7M | 0.02% |
2,899,415
-10,825,063
| -79% | -$345M |
|
535
Wolverine World Wide
WWW
$1.59B
| $96.5M | 0.02% |
4,051,429
+2,126,775
| +111% | +$43.2M |
|
536
Ingevity
NGVT
$2.6B
| $96.2M | 0.02% |
1,829,639
+279,800
| +18% | +$13.3M |
|
|
CEO
537
DELISTED
CNOOC Limited
CEO
| $95.3M | 0.02% |
844,572
-33,639
| -4% | -$3.8M |
|
538
Patrick Industries
PATK
$2.88B
| $95.2M | 0.02% |
2,332,166
-91,783
| -4% | -$2.78M |
|
539
Madrigal Pharmaceuticals
MDGL
$11.7B
| $95M | 0.02% |
838,981
-34,934
| -4% | -$3.44M |
|
540
Credicorp
BAP
$31.2B
| $94.8M | 0.02% |
709,439
+120,817
| +21% | +$17.2M |
|
541
Theravance Biopharma
TBPH
$875M
| $94.1M | 0.02% |
4,482,777
+315,254
| +8% | +$8.1M |
|
|
AVLR
542
DELISTED
Avalara, Inc.
AVLR
| $94.1M | 0.02% |
706,769
+182,781
| +35% | +$18M |
|
543
TriMas Corp
TRS
$1.45B
| $93.7M | 0.02% |
3,910,397
+389,245
| +11% | +$8.95M |
|
544
Saia
SAIA
$9.99B
| $93.4M | 0.02% |
840,057
-81,963
| -9% | -$7.86M |
|
545
Veeva Systems
VEEV
$34.4B
| $92.1M | 0.02% |
393,067
-2,064,823
| -84% | -$409M |
|
|
CLDR
546
DELISTED
Cloudera, Inc.
CLDR
| $92.1M | 0.02% |
7,238,403
-191,557
| -3% | -$1.84M |
|
|
RVNC
547
DELISTED
Revance Therapeutics, Inc.
RVNC
| $91.7M | 0.02% |
3,756,798
-1,869,621
| -33% | -$36.9M |
|
548
Valero Energy
VLO
$88.9B
| $91.7M | 0.02% |
1,559,346
+34,214
| +2% | +$2.04M |
|
549
Republic Services
RSG
$63.9B
| $91.5M | 0.02% |
1,115,493
-497,271
| -31% | -$40.1M |
|
550
Carpenter Technology
CRS
$28.3B
| $91.3M | 0.02% |
3,758,506
-797,893
| -18% | -$17.7M |
|
Similar funds
Wellington Management Group's Q2 2020 Portfolio in Review
As of Q2 2020, Wellington Management Group held 2,062 positions worth $449B, up 19% from $378B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wellington Management Group's Q2 2020 filing shows 180 new, 666 increased, 896 reduced and 228 closed positions. Its largest new stake was DraftKings: 11,003,857 shares worth $355M. The largest sale was Walmart Inc, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2020 buy was DraftKings: 11,003,857 shares worth $355M.
- Wellington Management Group added most to Procter & Gamble in Q2 2020, an estimated $1.89B increase.
- Wellington Management Group's biggest Q2 2020 reduction was Walmart Inc, cutting an estimated $1.54B.
- Wellington Management Group fully exited Raytheon Company in Q2 2020, selling an estimated $774M.
- Wellington Management Group's ten largest holdings make up 18% of its $449B portfolio in Q2 2020.
- Wellington Management Group opened 180 new positions and closed 228 in Q2 2020.
- Wellington Management Group's portfolio value rose 19% quarter-over-quarter to $449B.
Based on Wellington Management Group's 13F filing for Q2 2020, filed 14 Aug 2020.